SCHEMBL18748639

SCHEMBL18748639

c1ccc2c(c1)ccc1cc(-n3c4ccccc4c4c5ccccc5c5c6ccccc6sc5c43)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.34
ERBB2 P04626 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34
AHR P35869 1/20 0.34
PMM2 O15305 1/20 0.33
MPI P34949 1/20 0.33
PHOSPHO1 Q8TCT1 1/20 0.33
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
TP53 P04637 4/20 0.33
ALDH1A1 P00352 2/20 0.33
HIF1A Q16665 1/20 0.33
CYP1B1 Q16678 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 4/20 0.32
RXFP1 Q9HBX9 1/20 0.32
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19985912 0.94 HPRT1 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17427577 0.93 PMM2 (0.40) PMM2MPIPHOSPHO1TP53ALDH1A1
SCHEMBL18748634 0.92 PMM2 (0.36) PMM2MPIPHOSPHO1TP53ALDH1A1
SCHEMBL18960868 0.92 ERBB2 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18748701 0.91 PMM2 (0.36) PMM2MPIPHOSPHO1NQO1NQO2
SCHEMBL18748660 0.90 PMM2 (0.35) PMM2MPIPHOSPHO1TP53ALDH1A1
SCHEMBL18687749 0.90 ERBB2 (0.32) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18748644 0.88 PMM2 (0.37) PMM2MPIPHOSPHO1TP53ALDH1A1
SCHEMBL19961683 0.88 PMM2 (0.37) PMM2MPIPHOSPHO1NQO1NQO2
SCHEMBL19985929 0.88 TP53 (0.33) CYP1A2PMM2MPIPHOSPHO1NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760769-B2 Composition and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-09-19 US disclosed
US-11760769-B2 Composition and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-09-19 US disclosed
US-20230209856-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 US disclosed
US-20230209856-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 US disclosed
US-20230200102-A1 MIXED LAYER, METHOD OF PREPARING THE MIXED LAYER, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 US disclosed
US-20230200102-A1 MIXED LAYER, METHOD OF PREPARING THE MIXED LAYER, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 US disclosed
US-20200308201-A1 COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-10-01 US disclosed
EP-3715437-A1 COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2020-09-30 EP disclosed
US-20170110669-A1 ORGANIC LIGHT EMITTING DEVICE AND DISPLAY DEVICE HAVING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-04-20 US disclosed
US-20170110669-A1 ORGANIC LIGHT EMITTING DEVICE AND DISPLAY DEVICE HAVING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308201-A1 COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, LEF1 CYP1A2 47/4885ERBB2 3814/4885FYN 3703/4885
US-11760769-B2 Composition and organic light-emitting device including the same CRY1, CRY2, LEF1 CYP1A2 47/4885ERBB2 3814/4885FYN 3703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.